Monopar Therapeutics Inc. buy krebskrebs
Start price
26.07.22
/
50%
€2.08
Target price
26.07.23
€3.00
Performance (%)
-67.79%
End price
27.07.23
€0.67
Summary
This prediction ended on 27.07.23 with a price of €0.67. The BUY prediction by krebskrebs for Monopar Therapeutics Inc. performed very badly with a performance of -67.79%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Monopar Therapeutics Inc. | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by krebskrebs for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Monopar Therapeutics Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten